NeurogesX, Inc. NGSX Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
NeurogesX, Inc. NGSX Company Overview 

Stock Message Board http://investorshangout.com/search?q=NGSX&...mp;yt1=Go!

NeurogesX, Inc. NGSX Current Price and Quotes
Last Price 0.0083
Previous Close 0.0084 Open 0.0083
Daily Range 0.0083 - 0.0083 52wk Range 0.41 - 0.0042
Volume 5,200 Dividend N/A
Average Vol (3m) 76,778 Yield N/A
NeurogesX, Inc. NGSX
Company Information

999 Baker Street
Suite 200
San Mateo, CA 94404

Website: http://www.neurogesx.com
Phone: 650-358-3300
Email: inquiries@neurogesx.com

NeurogesX, Inc. NGSX
NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life.

The Company's lead product, Qutenza?, is currently approved in the United States and the European Union. Qutenza is available in the United States for the management of neuropathic pain associated with postherpetc neuralgia (PHN). In Europe, Qutenza is being mark...



NeurogesX, Inc. NGSX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Sep 30, 2012 10-Q
CIK 0001385830
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2000
Employees 35 a/o Mar 15, 2012
Company Officers/Contacts

Ron Martell CEO
Stephen Ghiglieri CFO
Stephen Peroutka CMO, EVP
Company Directors

Not Available
Service Providers

Auditor/Accountant
Ernst & Young LLP
5 Times Square
New York, NY, 10036-6530
United States

Legal Counsel
Morrison & Foerster LLP
12531 High Bluff Drive
San Diego, CA, 92130
United States

Investor Relations Firm
The Ruth Group
757 Third Avenue
New York, NY, 10017
United States


NeurogesX, Inc. NGSX
NGSX Security Details

Share Structure

Market Value1 $276,665 a/o Sep 12, 2013
Shares Outstanding 33,333,119 a/o Oct 31, 2012
Float Not Available
Authorized Shares 100,000,000 a/o Dec 17, 2012
Par Value  No Par Value
Shareholders

Shareholders of Record 48 a/o Mar 28, 2012
Security Notes

Note = Company delisted from NASDAQ on 06/29/12
Short Selling Data

Short Interest 841 (0%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



NeurogesX, Inc. NGSX Recent News

Sept 5, 2013 OTC Signal Daily Stock Watch - NeurogesX, Inc., (OTC:NGSX)


NeurogesX, Inc. NGSX Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 11,503 8,266 2,006 -
Cost of Revenue 685 541 - -
Gross Profit 10,818 7,725 2,006 -
Operating Expenses

Research and Development 13,566 11,151 11,235 16,104
Sales, General and Admin. 36,408 36,383 12,420 10,182
Non-Recurring Items - - - -
Other - - - -
Operating Income (39,156) (39,809) (21,649) (26,286)
Income From Continuing Operations

Add'l Income/Expense Items 16 706 58 1,043
Earnings Before Interest and Tax (39,140) (39,103) (21,591) (25,243)
Interest Expense 10,405 5,413 276 792
Earnings Before Tax (49,545) (44,516) (21,867) (26,035)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (49,545) (44,516) (21,867) (26,035)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (49,545) (44,516) (21,867) (26,035)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (49,545) (44,516) (21,867) (26,035)

NGSX NeurogesX, Inc. Research DD Guide

NGSX NeurogesX, Inc. Stock Message Board http://investorshangout.com/search?q=NGSX&...mp;yt0=Go!
NGSX NeurogesX, Inc. Stock Quote http://www.otcmarkets.com/stock/NGSX/quote
NGSX NeurogesX, Inc. Stock Chart http://www.otcmarkets.com/stock/NGSX/chart
NGSX NeurogesX, Inc. Company Info http://www.otcmarkets.com/stock/NGSX/company-info
NGSX NeurogesX, Inc. Recent News http://www.otcmarkets.com/stock/NGSX/news
NGSX NeurogesX, Inc. Financials http://www.otcmarkets.com/stock/NGSX/financials
NGSX NeurogesX, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/NGSX/filings
NGSX NeurogesX, Inc. Short Sales http://www.otcmarkets.com/stock/NGSX/short-sales
NGSX NeurogesX, Inc. Insider Disclosure http://www.otcmarkets.com/stock/NGSX/insider-transactions
NGSX NeurogesX, Inc. Research Reports http://www.otcmarkets.com/stock/NGSX/research
NGSX NeurogesX, Inc. Summary http://finance.yahoo.com/q?s=NGSX
NGSX NeurogesX, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=NGSX+Historical+Prices
NGSX NeurogesX, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=NGSX
NGSX NeurogesX, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=NGSX+Basic+Chart
NGSX NeurogesX, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NGSX+Basic+Tech.+Analysis
NGSX NeurogesX, Inc. Headlines http://finance.yahoo.com/q/h?s=NGSX+Headlines
NGSX NeurogesX, Inc. Press Releases http://finance.yahoo.com/q/p?s=NGSX+Press+Releases
NGSX NeurogesX, Inc. Company Profile http://finance.yahoo.com/q/pr?s=NGSX+Profile
NGSX NeurogesX, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=NGSX+Key+Statistics
NGSX NeurogesX, Inc. Industry http://finance.yahoo.com/q/in?s=NGSX+Industry
NGSX NeurogesX, Inc. Major Holders http://finance.yahoo.com/q/mh?s=NGSX+Major+Holders
NGSX NeurogesX, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=NGSX+Insider+Transactions
NGSX NeurogesX, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=NGSX+Insider+Roster
NGSX NeurogesX, Inc. Income Statement http://finance.yahoo.com/q/is?s=NGSX
NGSX NeurogesX, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=NGSX
NGSX NeurogesX, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=NGSX+Cash+Flow&annual
NGSX NeurogesX, Inc. Nasdaq http://www.nasdaq.com/symbol/NGSX
NGSX NeurogesX, Inc. Market Watch http://www.marketwatch.com/investing/stock/NGSX
NGSX NeurogesX, Inc. Bloomberg http://www.bloomberg.com/quote/NGSX:US
NGSX NeurogesX, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=NGSX
NGSX NeurogesX, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=NGSX
NGSX NeurogesX, Inc. Barchart http://www.barchart.com/quotes/stocks/NGSX
NGSX NeurogesX, Inc. OTC Short Report http://otcshortreport.com/index.php?index=NGSX
NGSX NeurogesX, Inc. Investopedia http://www.investopedia.com/markets/stocks/NGSX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 74

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 13

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 11

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 6

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 5

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 12

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 14

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 28

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 64

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 40 Years: The Evolution of Fudan SoM

Updated Category News Views 275

Fudan SoM Celebrates a Milestone in Business Education The Fudan University School of Management recently celebrated its 40th anniversary with great enthusiasm, showcasing a commitment to fostering global business education. This significant event coincided with the launch of the 2025 Global Business Education Deans' Forum and Expo, a pivotal gathering that highlights...

Continue Reading
ICU Medical Stock Hits Record Low: What Investors Should Know

Updated Category News Views 321

ICU Medical Faces Significant Market Challenges Amidst a turbulent market landscape, ICU Medical (NASDAQ: ICUI) has witnessed its stock price decline to a 52-week low of $1.69, resulting in a market capitalization plummeting to approximately $7.65 million. The company’s substantial dip in value, which is around -86.22% over the past year, highlights a significant...

Continue Reading
Sagimet Biosciences Unveils Comprehensive Financial Results and Milestones

Updated Category News Views 178

Sagimet Biosciences Shares 2024 Financial Highlights Sagimet Biosciences Inc. (NASDAQ: SGMT), a prominent clinical-stage biopharmaceutical firm focusing on innovative therapies for metabolic and fibrotic disorders, recently revealed its financial outcomes for the full year ended December 31, 2024. With notable advancements in their drug pipeline, Sagimet is...

Continue Reading
Exploring the Expanding Opportunities in Cannabidiol Market

Updated Category News Views 158

Cannabidiol Market Growth Projections The global cannabidiol (CBD) market is a rapidly evolving sector that is transforming the healthcare landscape. With increasing recognition of its therapeutic potential, the market was valued at approximately USD 8.97 billion in 2024 and is set to reach an impressive USD 38.97 billion by 2034. This remarkable growth, projected at a...

Continue Reading
Kelley Morris Appointed President of Hospital Foundations

Updated Category News Views 476

Kelley Morris Steps into Leadership Role The Memorial and Joe DiMaggio Children's Hospital Foundations have made a significant change in leadership by appointing Kelley Morris, MHA, as President and CEO. With an impressive background spanning over 25 years in healthcare philanthropy, operations, and research administration, Morris is set to lead the Foundations in...

Continue Reading